Risperidone
Risperidone
- Category
- pharmaceutical · Atypical antipsychotic
- Record
- specific compound · in current use
- Identifiers
- CAS 106266-06-2
- Aliases
- —
Atypical antipsychotic with a strong prolactin effect. Metabolic disruption is recorded as weaker than olanzapine in this seed.
Flags: pharmaceutical
Phase-1 numbers are seed hypotheses. They are not curated consensus, not a toxicity total, and not a statement of human risk. Association is not written as causation.
No regulatory assessment is stored. A classification from EFSA, EPA, or another agency would appear here as its own layer. It would not replace the mechanistic scores.